コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 by all three primary assays and in all four glycated 2D subfractions were significantly different be
3 CKD by fructosamine (C statistic 0.717) and glycated albumin (0.717) were nearly as strong as by HbA
4 eins, such as glycated hemoglobin (HbA1c) or glycated albumin (GA) in the blood, are essential indica
5 its daily variability, we compared HbA(1c), glycated albumin (GA), and seven-point glucose profile c
6 an HbA1c in meta-analysis (P = 0.0225), mean glycated albumin (P = 0.0029), and glyoxal hydroimidazol
7 HRs for CKD for people with fructosamine and glycated albumin above the 95th percentile were 1.50 (95
11 ifferences were found in the relationship of glycated albumin and fructosamine levels with the mean g
12 The extent of glycation measured in terms of glycated albumin and hemoglobin was reduced significantl
16 26), but HbA1c outperformed fructosamine and glycated albumin for prediction of incident diabetes wit
17 clarify the performance of fructosamine and glycated albumin measurements for identifying people at
19 baseline concentrations of fructosamine and glycated albumin were significantly associated with each
22 e evaluated associations of fructosamine and glycated albumin with risk of coronary heart disease, is
23 ssessed the associations of fructosamine and glycated albumin with risk of incident diabetes, retinop
24 , glycated hemoglobin (HbA1c), fructosamine, glycated albumin), and a latent variable for kidney func
26 d fasting glucose, insulin, adiponectin, and glycated albumin, as well as body mass index (BMI), use
28 case that repairs methylglyoxal- and glyoxal-glycated amino acids and proteins by acting on early gly
29 nes, arginines, and lysines (the three major glycated amino acids) of serum albumin, glyceraldehyde-3
35 backbone conformation from A to B form when glycated, but does not induce any final transition in DN
39 indicated the formation of hydrolysates and glycated compounds with different molecular weight distr
42 ity of N-phenacylthiazolium bromide (PTB), a glycated cross-link breaker, in the modulation of period
43 By using ESI-QTOF-MS technique, formation of glycated cytochrome C containing up to 12 glucose moieti
44 terial mutants displayed increased levels of glycated DNA and RNA and exhibited strong mutator phenot
48 depleted cells displayed increased levels of glycated DNA, DNA strand breaks, and phosphorylated p53.
50 lysates showed reduced fluorescence advanced glycated end-products (AGE) and a reduced amount of alph
51 ceptors (TLRs) and the receptor for advanced glycated end-products (RAGE), are upregulated within inf
52 e-associated molecular patterns and advanced glycated endproducts and can trigger cell activation.
56 Amadori rearrangements and the free and mono-glycated guanidine also formed imidazolinone derivatives
57 diabetes remission at 2 years, defined as a glycated haemaglobin A1c (HbA1c) concentration of 6.5% o
59 /=1500 mg/day), aged 18 years or older, with glycated haemoglobin (HbA1c) 7.0% or greater (>/=53 mmol
61 more, and remission of diabetes, defined as glycated haemoglobin (HbA1c) of less than 6.5% (<48 mmol
62 nge glucose and insulin measures, as well as glycated haemoglobin (HbA1c), are used to diagnose and m
64 lso associated with improvements in glucose, glycated haemoglobin (HbA1c), weight, waist circumferenc
67 years with established type 2 diabetes, mean glycated haemoglobin A1c (HbA1c) concentration of 67 mmo
69 ts aged 18-80 years with type 2 diabetes and glycated haemoglobin A1c (HbA1c) of 7.0-9.5% on stable m
70 function, lipid profile, glucose tolerance, glycated haemoglobin A1c, salivary cortisol, sitting hei
74 , systolic and diastolic blood pressures and glycated haemoglobin in the 1958 British Birth Cohort (1
76 h advanced type 2 diabetes do not meet their glycated haemoglobin targets and randomised controlled s
77 = 32), and were correlated with the level of glycated haemoglobin, glycaemic level, and time of disea
78 least two creatinine, thyrotropin, calcium, glycated haemoglobin, or lithium measurements between Oc
79 It was observed that patients with elevated glycated Hb levels also had higher levels of HSA glycati
83 d 10.2 percentage points, respectively), and glycated hemoglobin (10.1 percentage points and 9.4 perc
84 omol/L [IQR, 72-89 micromol/L], P = .61) and glycated hemoglobin (5.9% [IQR, 5.6%-6.1%] vs 5.9% [IQR,
86 sted difference, 1.0 percentage points), and glycated hemoglobin (adjusted difference, 3.4 percentage
87 liflozin group than in the placebo group for glycated hemoglobin (difference, -0.46 percentage points
89 oad glucose (PG), 2-h postload insulin (PI), glycated hemoglobin (Hb A1c), and homeostasis model asse
90 s: colorectal screening rates; diabetes with glycated hemoglobin (HbA1c level) less than 9.0%; diabet
92 ype 2 diabetes were recruited: subjects with glycated hemoglobin (HbA1c) </=7% and subjects with HbA1
93 ; betaPFOA=1.71 pM; 95% CI: 0.72, 2.71), and glycated hemoglobin (HbA1c) (betaPFOS=0.03%; 95% CI: 0.0
94 ) concentration (-37.0 mg/dL; P < 0.001) and glycated hemoglobin (HbA1c) [-0.97% (-10.6 mmol/mol); P
95 nt increases in hippocampal FC, decreases in glycated hemoglobin (HbA1c) and body fat, and increases
103 lycemia from birth, resulting in an elevated glycated hemoglobin (HbA1c) level that mimics recommende
104 ex, waist circumference, fat percentage, and glycated hemoglobin (HbA1c) level were recorded chairsid
105 n leakage area at month 36 (P = 0.0137), and glycated hemoglobin (HbA1c) levels at month 36 (P = 0.00
106 ed the association between periodontitis and glycated hemoglobin (HbA1c) levels in individuals withou
107 (20-50 U) and metformin (>/=1500 mg/d) with glycated hemoglobin (HbA1c) levels of 7% to 10% and a bo
108 nfluence of periodontal status on changes of glycated hemoglobin (HbA1c) levels of patients with type
112 hievement of good glycemic control, of which glycated hemoglobin (HbA1c) remains the standard clinica
113 in or loss and glycemic control (assessed by glycated hemoglobin (HbA1c) values) in patients from the
116 glucose, C-reactive protein, triglycerides, glycated hemoglobin (HbA1c), and total, low-density lipo
117 The relationship between delayed GE and glycated hemoglobin (HbA1c), complications of DM, and ga
118 eplacement of other sugars and its effect on glycated hemoglobin (HbA1c), fasting blood glucose, insu
119 agnostic accuracies of random blood glucose, glycated hemoglobin (HBA1c), fructosamine, and Homeostas
120 glycemia (diabetes status, fasting glucose, glycated hemoglobin (HbA1c), fructosamine, glycated albu
121 ent of glycated blood proteins, particularly glycated hemoglobin (HbA1c), is an important diagnostic
123 ed with the diabetes GRS on fasting insulin, glycated hemoglobin (HbA1c), the homeostasis model asses
125 led trials (RCTs) that assessed the outcomes glycated hemoglobin (HbA1c), weight, body mass index (BM
129 body mass index (in kg/m(2)): 34.6 +/- 4.3; glycated hemoglobin (HbA1c): 7.3 +/- 1.1%; duration of d
130 n [n = 136; mean +/- SD age: 12.8 +/- 2.6 y; glycated hemoglobin (HbA1c): 8.1% +/- 1.0%; 69.1% using
131 .7%) was associated with a reduction in mean glycated hemoglobin (HbA1c, -1.3 +/- 1.8%, P < 0.001), f
135 y; median (IQR), 10 (5-9) y of T2D duration; glycated hemoglobin 7.0% +/- 0.8%; body mass index (in k
136 8 of whom had poor glycemic control (average glycated hemoglobin [HbA1c] >/=8% during the year) while
137 tensive glycemic control in type 2 diabetes (glycated hemoglobin [HbA1c] level <7%) is an established
138 cose [RBG], fasting blood glucose [FBG], and glycated hemoglobin [HbA1c]) and survival in all lung tr
139 g plasma glucose >/=200 mg/dl (11.1 mmol/l), glycated hemoglobin A1c (HbA1c) >6.5%, self-reported phy
140 nfidence intervals (CIs) were calculated for glycated hemoglobin A1c (HbA1c), fasting plasma glucose
141 se [FCG] level, 2-hour CG [2-hCG] level, and glycated hemoglobin A1c [HbA1c] level) at enrollment, an
143 While adjusting for duration of diabetes, glycated hemoglobin A1c level, and other factors, we fou
146 ciation of baseline waist circumference with glycated hemoglobin A1c reduction is likely due to selec
148 are well-adhered to, whereas guidelines for glycated hemoglobin A1c testing for type 2 diabetes mell
151 We collected data on histories of patients' glycated hemoglobin A1c, hypertension, hyperlipidemia, s
152 tions, pain (numeric rating scale), level of glycated hemoglobin A1c, level of C-reactive protein, bo
153 y is to investigate the relationship between glycated hemoglobin and circulating levels of interleuki
154 rvention also produced greater reductions in glycated hemoglobin and greater initial improvements in
155 ic red blood cells correlates with levels of glycated hemoglobin and that the mechanical properties o
156 of Germany or Austria), body mass index, and glycated hemoglobin as covariates were used to account f
157 iculated thrombocytosis that correlates with glycated hemoglobin as well as increased plasma S100A8/A
158 e variation, complicates the clinical use of glycated hemoglobin assays for the diagnosis and managem
159 ears after baseline on the basis of either a glycated hemoglobin concentration of at least 6.5% or us
160 moglobin glycation index (HGI), a measure of glycated hemoglobin controlled for blood glucose variati
161 s improved, for example, fasting glucose and glycated hemoglobin decreased from 6.1 to 5.4 mmol/mol a
165 h both incidence of T2D and increased plasma glycated hemoglobin in individuals without T2D, providin
166 and with low HDL concentrations and elevated glycated hemoglobin in obese and diabetic patients.CCK r
167 closures do not affect health in general, 2) glycated hemoglobin is insensitive to local foreclosure
168 dard therapy or aggressive therapy (targets: glycated hemoglobin level <6.0%, low-density lipoprotein
169 val [CI], 0.8 to 15.0) for glycemic control (glycated hemoglobin level <7.0%), 9.4 percentage points
170 ed optimal diabetes care (n = 448) (targets: glycated hemoglobin level <7.0%, low-density lipoprotein
171 wer; 95% CI, 24 to 51; P<0.001) and the mean glycated hemoglobin level (difference, -0.3%; 95% CI, -0
172 , 1.02; 95% CI, 1.01-1.04) and knowing one's glycated hemoglobin level (odds ratio, 2.00; 95% CI, 1.3
174 os for death from any cause according to the glycated hemoglobin level for patients with diabetes as
177 n, the proportion of patients who achieved a glycated hemoglobin level lower than 7.0% with no severe
179 was 1.0% over 5 years among patients with a glycated hemoglobin level of 6%, as compared with 4.3% o
182 diagnosis of obstructive sleep apnea, with a glycated hemoglobin level of 6.5-8.5%, and an oxygen des
183 ients younger than 55 years of age who had a glycated hemoglobin level of 6.9% or less (</=52 mmol pe
184 ng those younger than 55 years of age with a glycated hemoglobin level of 6.9% or less, as compared w
185 trols were 2.36 (95% CI, 1.97 to 2.83) for a glycated hemoglobin level of 6.9% or lower (</=52 mmol p
186 l study, patients with type 1 diabetes and a glycated hemoglobin level of 6.9% or lower had a risk of
187 , but intensive glucose control, targeting a glycated hemoglobin level of less than 6.5%, did not.
188 e patient's current state of retinopathy and glycated hemoglobin level reduced the frequency of eye e
189 r mean percentage reduction from baseline in glycated hemoglobin level than did patients who received
192 iabetes was 16.4 years, and the mean (+/-SD) glycated hemoglobin level was 8.4+/-1.7%; 83.9% of the p
193 s was 49+/-8 years, 66% were women, the mean glycated hemoglobin level was 9.2+/-1.5%, and the mean B
194 /-8 years, 68% were women, the mean baseline glycated hemoglobin level was 9.3+/-1.5%, and the mean b
195 etes had poor glycemic control (mean [+/-SD] glycated hemoglobin level, 9.0+/-2.4%), and the rates of
196 points included the change from baseline in glycated hemoglobin level, weight, systolic blood pressu
202 f 3.0 years, there was a small difference in glycated hemoglobin levels (least-squares mean differenc
203 The phenomenon of a discrepancy between glycated hemoglobin levels and other indicators of avera
205 ween-group differences in blood pressure and glycated hemoglobin levels during the trial were no long
208 we observed no significant effect on average glycated hemoglobin levels or on the percentage of parti
209 e fully attenuated after adjustment for mean glycated hemoglobin levels over the entire follow-up.
210 sults show that interindividual variation in glycated hemoglobin levels was evident in diabetes patie
215 Interindividual and ethnic variation in glycated hemoglobin levels, unrelated to blood glucose v
221 ere among metabolic surgery patients (higher glycated hemoglobin levels; greater percentage of insuli
222 es included blood-pressure, cholesterol, and glycated hemoglobin levels; screening for depression; me
225 /m(2)) of 39.2 (95% CI: 35.2, 43.3) and mean glycated hemoglobin of 5.3% (95% CI: 4.9%, 5.6%), were s
226 the intention-to-treat population, the mean glycated hemoglobin profile improved in the intervention
228 mg per deciliter (2.6 mmol per liter), and a glycated hemoglobin value of 9.0% or lower, according to
229 ological factors assessed, insulin index and glycated hemoglobin values explained 15% and 16% of the
232 rular basement membrane and higher levels of glycated hemoglobin were independent predictors of progr
233 rs are modestly effective in reducing HbA1c (glycated hemoglobin) ( approximately 0.5%) and while the
234 hod for measuring the hemoglobin A1c (HbA1c, glycated hemoglobin) concentration, hemoglobin (Hb) conc
237 syndrome (69.2 vs. 51.9%), fast glycemia and glycated hemoglobin, albuminuria, triglycerides and uric
238 cholesterol, triglycerides, blood pressure, glycated hemoglobin, and fasting glucose and report the
239 ar reductions in insulin, insulin C-peptide, glycated hemoglobin, and homeostasis model assessment of
240 e intervention group had significantly lower glycated hemoglobin, fasting plasma glucose, plaque inde
241 justment for metabolic biomarkers, including glycated hemoglobin, high-density lipoprotein cholestero
243 ptical coherence tomography, blood pressure, glycated hemoglobin, medications, and changes in such pa
244 positive correlation of chemerin with IL-6, glycated hemoglobin, sampled-site clinical attachment le
245 meters controlling for sex, body mass index, glycated hemoglobin, use of oral hypoglycemic drugs, and
251 d by measurement of the cutoff ratio between glycated hemoglobins (HbA1c) and total hemoglobin (Hb),
255 ntified peptides in the enriched fraction as glycated, high sensitivity for detection of glycated pep
256 method is not limited to clinical samples of glycated HSA but could be adapted for work with other mo
257 on approach was developed to isolate HSA and glycated HSA from clinical samples, using only 20 muL of
258 in binding by sulfonylurea drugs to in vivo glycated HSA that had been isolated from individual pati
261 of glycated peptides quantified in in vitro glycated human plasma increased more than 3-fold using t
262 and modified DNA aptamers specifically bound glycated human serum albumin (GHSA), which is an interme
265 trast, only 168 polypeptides contained early glycated lysines, which did not resemble the sites of ad
267 lpha overexpression significantly suppressed glycated or acetylated low-density lipoprotein-induced c
270 lysis of the modified ubiquitin and isomeric glycated peptides (fragments of bovine serum albumin (BS
273 glycated, high sensitivity for detection of glycated peptides with LOD and LOQ at 1.2 and 2.4 pg, re
276 rabidopsis thaliana The absence of the early glycated precursors of the AGE-modified protein residues
277 oducible online 2D platform is promising for glycated protein analysis of complex clinical samples.
278 n in exposed splenocyte, were evident in the glycated protein treated mice as compared to its native
283 e detection and identification of individual glycated proteins in complex samples using fluorescent b
286 hree aging-specific and eight differentially glycated proteins, four of which were modified in cataly
290 -related changes in the Arabidopsis thaliana glycated proteome, including the proteins affected and s
292 to 12 glucose moieties were observed, while glycated species containing 6 and 8 glucose moieties wer
293 rameters with the levels of glycosylated and glycated species in a series of small scale experiments,
295 Cytochrome C had multiple charges in non-glycated state, primarily changing from +13 to +17 posit
299 ocess (ISP) was hydrolysed with Alcalase and glycated with glucosamine (GlcN) at moderate temperature
300 rmal stability and antioxidative capacity of glycated WP were increased, especially in the presence o
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。